Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
894 USD | -0.80% | -2.86% | +1.79% |
Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
Apr. 17 | The market is pinning its hopes on earnings reports |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.